Literature DB >> 8041794

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

S A Kliewer1, B M Forman, B Blumberg, E S Ong, U Borgmeyer, D J Mangelsdorf, K Umesono, R M Evans.   

Abstract

To gain insight into the function of peroxisome proliferator-activated receptor (PPAR) isoforms in mammals, we have cloned and characterized two PPAR alpha-related cDNAs (designated PPAR gamma and -delta, respectively) from mouse. The three PPAR isoforms display widely divergent patterns of expression during embryogenesis and in the adult. Surprisingly, PPAR gamma and -delta are not activated by pirinixic acid (Wy 14,643), a potent peroxisome proliferator and activator of PPAR alpha. However, PPAR gamma and -delta are activated by the structurally distinct peroxisome proliferator LY-171883 and linoleic acid, respectively, indicating that each of the isoforms can act as a regulated activator of transcription. These data suggest that tissue-specific responsiveness to peroxisome proliferators, including certain fatty acids, is in part a consequence of differential expression of multiple, pharmacologically distinct PPAR isoforms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041794      PMCID: PMC44398          DOI: 10.1073/pnas.91.15.7355

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.

Authors:  M R Nemali; N Usuda; M K Reddy; K Oyasu; T Hashimoto; T Osumi; M S Rao; J K Reddy
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

3.  Nuclear receptor that identifies a novel retinoic acid response pathway.

Authors:  D J Mangelsdorf; E S Ong; J A Dyck; R M Evans
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

Review 4.  Biogenesis of peroxisomes.

Authors:  P B Lazarow; Y Fujiki
Journal:  Annu Rev Cell Biol       Date:  1985

Review 5.  Pathophysiology of peroxisomal beta-oxidation.

Authors:  J Vamecq; J P Draye
Journal:  Essays Biochem       Date:  1989       Impact factor: 8.000

6.  Effect of the peroxisome proliferator LY171883 on triglyceride accumulation in rats fed a fat-free diet.

Authors:  P S Foxworthy; P I Eacho
Journal:  Biochem Pharmacol       Date:  1991-09-12       Impact factor: 5.858

7.  Stereological analysis of the guinea pig adrenal: effects of dexamethasone and ACTH treatment with emphasis on the inner cortex.

Authors:  V H Black; J J Russo
Journal:  Am J Anat       Date:  1980-09

8.  Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

Authors:  Y Zhu; K Alvares; Q Huang; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

9.  The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response.

Authors:  J L Arriza; R B Simerly; L W Swanson; R M Evans
Journal:  Neuron       Date:  1988-11       Impact factor: 17.173

10.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

Authors:  K Umesono; K K Murakami; C C Thompson; R M Evans
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

View more
  333 in total

1.  IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1.

Authors:  A C Bendixen; N K Shevde; K M Dienger; T M Willson; C D Funk; J W Pike
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 2.  Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression.

Authors:  Marc van Bilsen; Ger J van der Vusse; Andries J Gilde; Martijn Lindhout; Karin A J M van der Lee
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

4.  Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.

Authors:  Y F Guan; Y H Zhang; R M Breyer; L Davis; M D Breyer
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

5.  Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.

Authors:  Anne R Diers; Brian P Dranka; Karina C Ricart; Joo Yeun Oh; Michelle S Johnson; Fen Zhou; Manuel A Pallero; Thomas M Bodenstine; Joanne E Murphy-Ullrich; Danny R Welch; Aimee Landar
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

6.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 7.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 8.  Control of macrophage activation and function by PPARs.

Authors:  Ajay Chawla
Journal:  Circ Res       Date:  2010-05-28       Impact factor: 17.367

9.  Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma.

Authors:  Michaela Svobodova; Ioanna Andreadou; Alexios-Leandros Skaltsounis; Jan Kopecky; Pavel Flachs
Journal:  Genes Nutr       Date:  2013-12-10       Impact factor: 5.523

10.  RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart.

Authors:  Laïla Ouamrane; Gilberte Larrieu; Béatrice Gauthier; Thierry Pineau
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.